Cancer Patients Face Discrimination at Work

by Shirley Johanna on November 7, 2016 at 8:15 PM
Cancer Patients Face Discrimination at Work

About 18 percent of people diagnosed with cancer face discrimination at work, finds a survey by the charity Macmillan.

Thirty-five percent of people with a cancer diagnosis told of negative experiences, including guilt at taking time off for medical appointments and losing faith in their ability to do the job.


The survey of 1,009 patients, all in work when diagnosed, indicated that 15% returned to work before feeling ready and 14% quit or were made redundant as a result of their diagnosis.

More than 20,000 people a year diagnosed with cancer will face discrimination. People of working age with cancer will hit 1.7 million by 2030, according to the report. Liz Egan, of Macmillan Cancer Support, said, "It's appalling that, during an already difficult, often stressful time, so many employers are not offering the right support to people with cancer, leaving little choice but to leave."

The survey found that 85 percent of those diagnosed with cancer felt keeping on working was important. Work helped 60 percent keep a sense of normality, whereas 45 percent worked for the money.

Source: Medindia
Font : A-A+



Recommended Readings

Latest Cancer News

Blood Test for Early Detection of Pancreatic Cancer
The blood test pinpointed 13 proteins capable of distinguishing between early and late stages of pancreatic cancer.
Nutrients in Beef and Dairy Promote Cancer Immunotherapy
A fatty acid present in dairy products, beef, and lamb called trans-vaccenic acid enhances immune cells' capacity to combat cancers.
Combination Therapy Holds Promise for Brain Tumor in Children
Trametinib plus dabrafenib combined therapy demonstrated a clear therapeutic benefit in children with BRAF-mutated low- and high-grade gliomas.
Urban Environments Fuel Higher Breast Cancer Rates
Examining breast cancer occurrence and stages reveals disparities in urban versus rural rates, influenced by environmental conditions and the stage of the disease.
DNA Repair Pathway Linked to Breast, Ovarian, and Prostate Cancers
Polymerases theta and delta assist in the development of new cancer drugs known as polymerase theta inhibitors, currently undergoing clinical trials.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Cancer Patients Face Discrimination at Work Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests